Clinical Trials Browser

Phase 1 × sapacitabine × 30 days × Clear all

NCT03641755 2026-02-23

Olaparib + Sapacitabine in BRCA Mutant Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms